As mentioned above, an important function of cGAS-STING signaling pathway activation is to recruit tumor-specific immune cells via DCs, and thus we have reason to believe that combining cGAS-STING signaling pathway activators with PD-1/PD-L1 specific blockade will certainly greatly improve the efficacy. This evidence concerns the gene CGAS and neoplasm.